(1 - 11 von 12
)
UPDATE 2-Arpida at all-time low on funding concerns | Reuters
www.reuters.com
Shares in Swiss biotech company Arpida slumped to an all-time low of Swiss francs on concerns the company could need fresh funding even after it...
Arpida gibt die Hoffnung noch nicht ganz auf | Handelszeitung
www.handelszeitung.ch
Der Forschungschef, Sergio Lociuro, und der Entwicklungschef, Paul Hadvary, werden das Unternehmen zudem «im gegenseitigen Einvernehmen» verlassen. › Unternehmen
UPDATE 1-Arpida says cost cuts to stem cash burn
www.finanznachrichten.de
Arpida also announced Sergio Lociuro, Head of Research, and Paul Hadvary, Head of Development, would be leaving. The news comes after ...
Arpida cuts 75% of workforce "in order to buy time" - PharmaTimes
www.pharmatimes.com
Switzerland’s Arpida says that its board of directors has approved a recently-announced set of cost-cutting measures as it gets to grips with a US regulatory...
sortiert nach Relevanz / Datum